Stay updated on Pembrolizumab and Acalabrutinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Acalabrutinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Acalabrutinib in NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page displays Revision: v3.5.4, replacing the previous Revision: v3.5.3. This indicates a newer build of the page's interface without changes to the study information.
    Difference
    0.1%
    Check dated 2026-05-15T05:31:14.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page’s displayed software release/revision indicator was updated from v3.5.2 to v3.5.3, reflecting a website version change rather than any modification to the study record.
    Difference
    0.1%
    Check dated 2026-04-24T05:48:17.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. No visible content or functionality changes.
    Difference
    0.1%
    Check dated 2026-04-17T02:17:11.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Revision tag updated to v3.5.0, replacing the previous v3.4.3. No study content or results are impacted.
    Difference
    0.1%
    Check dated 2026-03-19T01:13:35.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T17:48:49.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    The page shows a new site revision note (Revision: v3.4.2) and removes an older funding-status warning and Revision: v3.4.1; these are maintenance updates rather than changes to the trial details or data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T02:50:23.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Acalabrutinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Acalabrutinib in NSCLC Clinical Trial page.